Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Reuben Benjamin"'
Autor:
Richard Sullivan, Saoirse Dolly, Gincy George, Piers E.M. Patten, Kieran Palmer, Elinor J. Sawyer, Andrea D'Souza, James Spicer, Simon Gomberg, Reuben Benjamin, Paul Ross, Kamarul Zaki, Anna Haire, Ailsa Sita-Lumsden, Austin G. Kulasekararaj, Sophie Papa, Fidelma Cahill, Muhammed Mansour Ceesay, Victoria Potter, Sheeba Irshad, Thinzar Ko Ko, Mieke Van Hemelrijck, Beth Russell, Debra H. Josephs, Claire N. Harrison, Paul Fields, Danielle Crawley, Antonio Pagliuca, Vallari Shah, Deborah Enting, Rushan Sylva, Angela Swampillai, Harriet Wylie, Charlotte Moss, Anne Rigg, David Wrench, Shahram Kordasti, Maria J. Monroy-Iglesias
Publikováno v:
British Journal of Cancer
Background Using an updated dataset with more patients and extended follow-up, we further established cancer patient characteristics associated with COVID-19 death. Methods Data on all cancer patients with a positive reverse transcription-polymerase
Autor:
Reuben Benjamin, Nitin Jain, Marcela V Maus, Nicolas Boissel, Charlotte Graham, Agnieszka Jozwik, Deborah Yallop, Marina Konopleva, Matthew J Frigault, Takanori Teshima, Koji Kato, Floriane Boucaud, Svetlana Balandraud, Athos Gianella-Borradori, Florence Binlich, Ibtissam Marchiq, Sandra Dupouy, Maria Almena-Carrasco, Matthieu Pannaux, Sylvain Fouliard, Eolia Brissot, Mohamad Mohty, Laarni Bonganay, Lorraine Catt, Jackie Chappell, Gary Cheung, Vicky Chu, Kirsty Cuthill, Steven Devereux, Alan Dunlop, Rose Ellard, Farzin Farzeneh, Najeem Folarin, Elka Giemza, Shireen Kassam, Majid Kazmi, Andrea Kuhnl, Jen Lewis, Maria Liskova, Alice Mason, Victoria Metaxa, Ghulam Mufti, Helena Munro, Antonio Pagliuca, Piers Patten, Victoria Potter, Carmel Rice, Adeel Saleem, Robin Sanderson, Orla Stewart, Elias Jabbour, Emily Jones, Hagop Kantarjian, Partow Kebriaei, Kara McGee, William Wierda, Jami Brown, Keagan Casey, Matthew Frigault, Hanno Hock, Richard Mathews, Marcela Maus, Meaghan A McKeown, Thomas Spitzer, Vesselina Toncheva, Elie Azoulay, Sophie Caillat-Zucman, Karine Celli-Lebras, Emmanuelle Clappier, Raphael Itzykson, Jérôme Larghero, Etienne Lengliné, Isabelle Madelaine, Martine Meunier, Florence Rabian, Emmanuel Raffoux, Marie-Thérèse Tremorin, Agnes Bonnin, Anne Daguenel-Nguyen, Remy Dulery, Tounes Ledraa, Florent Malard, Clemence Mediavilla, Anne Vekhoff
Publikováno v:
The Lancet. Haematology. 9(11)
The prognosis for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia remains poor. UCART19, an allogeneic genome-edited anti-CD19 chimeric antigen receptor (CAR) T-cell product derived from healthy donors and available for immedi
Autor:
Marie-Therese Rubio, Roberta Di Blasi, Gilles Salles, Miguel A Perales, Kada Klouche, Muriel Picard, Pierre Sesques, Eric Mariotte, Michael Darmon, Boris Böll, Philippe R. Bauer, Sanjay Chawla, Kevin Rakszawski, Nahema Issa, Anne Huynh, Guillaume Cartron, Florence Rabian, Peter Borchmann, Michael Joannidis, Sabine Furst, Sophie de Guibert, Lara Zafrani, Patrice Ceballos, Nicolas Boissel, David Beauvais, Catherine Thieblemont, François-Xavier Gros, Alberto Mussetti, Gabriel Moreno-González, Adel Maamar, Florent Wallet, Faezeh Legrand, Julien Leroy, Quentin Quelven, Djamel Mokart, Valentin Ortiz, Christian Recher, Jakob Rudzki, Laura Platon, Pleun Hemelaar, Benoit Tessoulin, Reuben Benjamin, Sandrine Valade, Pedro Castro, Gennadii Galstian, Amélie Seguin, Peter Schellongowski, Anna Sureda, Alice Gallo De Moraes, Philipp Wohlfarth, Bruno Levy, Andry Van de Louw, Jorge Garcia Borrega, Julio Delgado, Ibrahim Yakoub-Agha, Nathalie Fégueux, Laveena Munshi, Yi Lin, Emmanuel Bachy, Stéphanie Harel, Sara Fernández, Bertrand Arnulf, Thomas Gastinne, Elie Azoulay, Didier Blaise, Amandine Le Bourgeois, Louis Voigt, Cécile Borel, Anne-Sophie Moreau, Christian Chabannon, Ulrich Jäger, Virginie Lemiale, Olga Gavrilina, Victoria Metaxa, Thomas Staudingert, Edouard Forcade
Publikováno v:
The Lancet Haematology
The Lancet Haematology, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
The Lancet Haematology, Elsevier, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
Lancet Haematology, 8, E355-E364
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Haematology, 8, 5, pp. E355-E364
The Lancet Haematology, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
The Lancet Haematology, Elsevier, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
Lancet Haematology, 8, E355-E364
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Haematology, 8, 5, pp. E355-E364
Summary Background Chimeric antigen receptor (CAR) T-cell therapy can induce side-effects such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (ICANS), which often require intensive care unit admission. The aim
Autor:
Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jozwik, Oana C Mirci-Danicar, Giovanna Lucchini, Danielle Pinner, Nitin Jain, Hagop Kantarjian, Nicolas Boissel, Marcela V Maus, Matthew J Frigault, André Baruchel, Mohamad Mohty, Athos Gianella-Borradori, Florence Binlich, Svetlana Balandraud, Fabien Vitry, Elisabeth Thomas, Anne Philippe, Sylvain Fouliard, Sandra Dupouy, Ibtissam Marchiq, Maria Almena-Carrasco, Nicolas Ferry, Sylvain Arnould, Cyril Konto, Paul Veys, Waseem Qasim, Antonio Pagliuca, Ghulam Mufti, Piers Patten, Shireen Kassam, Stephen Devereux, Majid Kazmi, Kirsty Cuthill, Victoria Potter, Andrea Kuhnl, Victoria Metaxa, Laarni Bonganay, Orla Stewart, Rose Ellard, Lorraine Catt, Jen Lewis, Farzin Farzaneh, Jackie Chappell, Alice Mason, Vicky Chu, Alan Dunlop, Adeel Saleem, Gary Cheung, Helena Munro, Elka Giemza, Oana Ciocarlie, Jan Chu, Persis Amrolia, Kanchan Rao, Robert Chiesa, Juliana Silva, Annette Hill, Maria Finch, Lindsey Young, Harvinder Hara, Sujith Samarasinghe, Anupama Rao, Ajay Vora, Kimberley Gilmour, Christine Rivat, Clare Murphy, Gulrukh Ahsan, Rasha Said Shamsah, Jesmina James, Sarah Inglott, Gary Wright, Stuart Adams, Natalia Izotova, Marina Konopleva, William Wierda, Elias Jabbour, Partow Kebrieai, Emily Jones, Kara McGee, Marcela Maus, Matthew Frigault, Jami Brown, Vesselina Toncheva, Keagan Casey, Hanno Hock, Meaghan A McKeown, Richard Mathews, Thomas Spitzer, Emmanuel Raffoux, Etienne Lengliné, Raphael Itzykson, Florence Rabian, Jérôme Larghero, Isabelle Madelaine, Elie Azoulay, Emmanuelle Clappier, Sophie Caillat-Zucman, Martine Meunier, Karine Celli-Lebras, Marie-Thérèse Tremorin, Karima Yakouben, Françoise Mechinaud-Heloury, Audrey Grain, Aurélia Alimi, Julie Roupret, Delphine Chaillou, Hélène Cavé, Aurelie Caye-Eude, Odile Fenneteau, Elodie Lainey, Jerome Naudin, Eolia Brissot, Remy Dulery, Florent Malard, Clémence Mediavilla, Agnès Bonnin, Anne Vekhoff, Tounes Ledraa, Anne Daguenel-Nguyen
Publikováno v:
The Lancet. 396:1885-1894
Summary Background Genome-edited donor-derived allogeneic anti-CD19 chimeric antigen receptor (CAR) T cells offer a novel form of CAR-T-cell product that is available for immediate clinical use, thereby broadening access and applicability. UCART19 is
Autor:
Sheeba Irshad, Paul Fields, Doraid Alrifai, Richard Davis, Yin Wu, Isaac Francos Quijorna, Anna Lorenc, Eva Bugallo-Blanco, Julie Nuo En Chan, Anne Rigg, Jennifer Vidler, Adrian Hayday, Aadil A. Khan, Julien de Naurois, Charlotte Moss, Sultan Abdul-Jawad, Pierre Vantourout, Louisa Mcdonald, Duncan R. McKenzie, Mieke Van Hemelrijck, Paul R. Barber, Irene del Molino del Barrio, Sophie Papa, Katharine Bailey, Deborah Enting, Beth Russell, Sophie Hazell, Sarah Gee, Tony Ng, Sarah Ryan, You Zhou, Anthony C. C. Coolen, Iva Zlatareva, Piers E.M. Patten, Adam Laing, Sophia N. Karagiannis, Miguel Muñoz-Ruiz, Luca Bau, Thomas Hayday, Yadanar Lwin, Shraddha Kamdar, Matthew Fish, Reuben Benjamin, Rozalyn Yorke, Aislinn Jennings, Katie J. Doores, Mayur Kumar, Thanussuyah Alaguthurai, Leticia Monin, Mark Rowley, James Spicer
Publikováno v:
Cancer Cell
Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid can
Autor:
P. Moreau, Maria Gavriatopoulou, Reuben Benjamin, Tuphan Kanti Dolai, Moshe Yair Levy, Vadim A Doronin, Paul G. Richardson, Hang Quach, Maryana Simonova, Ludek Pour, Don A. Stevens, Halyna Pylypenko, Thierry Facon, Xavier Leleu, Melina Arazy, Christopher P. Venner, Larry D. Anderson, Ashraf Z. Badros, Dinesh Kumar Sinha, Nizar J. Bahlis, Maria-Victoria Mateos, Jatin P. Shah, Sebastian Grosicki, Michele Cavo, Ganna Usenko, Yi Chai, Ivan Spicka, Sundar Jagannath, Roman Hájek, Meletios A. Dimopoulos, Michael Kauffman, Iryna Kriachok, Mamta Garg, Sharon Shacham, Holger W. Auner, Sosana Delimpasi
Elderly and frail patients with multiple myeloma (MM) are more vulnerable to the toxicity of combination therapies, often resulting in treatment modifications and suboptimal outcomes. The phase 3 BOSTON study showed that once-weekly selinexor and bor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98a9cd6d43172e2122cda2b0568bd327
https://hdl.handle.net/11585/865006
https://hdl.handle.net/11585/865006
Autor:
Hua Chang, Nizar J. Bahlis, Jatin P. Shah, Yi Chai, Shambavi Richard, Sosana Delimpasi, Ganna Usenko, Halyna Pylypenko, Meletios A. Dimopoulos, Holger W. Auner, Don A. Stevens, Ajai Chari, Reuben Benjamin, Melina Arazy, Moshe Yair Levy, Tuphan Kanti Dolai, Ivan Spicka, Hang Quach, Larry D. Anderson, Paul G. Richardson, Xavier Leleu, Maria-Victoria Mateos, Ashraf Z. Badros, Sharon Shacham, Iryna Kriachok, Thierry Facon, Roman Hájek, Sebastian Grosicki, Maryana Simonova, Ludek Pour, Yosef Landesman, Christopher P. Venner, Mamta Garg, Michael Kauffman, Dinesh Kumar Sinha, P. Moreau, Michele Cavo, Sundar Jagannath
Publikováno v:
American Journal of Hematology
In the phase 3 BOSTON study, patients with multiple myeloma (MM) after 1–3 prior regimens were randomized to once-weekly selinexor (an oral inhibitor of exportin 1 [XPO1]) plus bortezomib-dexamethasone (XVd) or twice-weekly bortezomib-dexamethasone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30983d9174caa7eac69167b8271b4ec6
https://hdl.handle.net/11585/865100
https://hdl.handle.net/11585/865100
Autor:
Andrew I Rutherford, John R Jones, Sharon Cain, Kit Hui, Tasneem Pirani, Austin G. Kulasekararaj, Henry Wood, James Galloway, Tracey Mare, Reuben Benjamin, Victoria Metaxa
Publikováno v:
British Journal of Haematology
Severe cases of COVID‐19, caused by novel coronavirus SARS‐CoV‐2, have been associated with a hyperinflammatory state.(Huang, Wang et al. 2020) This has been described as a form of secondary haemophagocytic lymphohistiocytosis (sHLH)(Bergsten,
Autor:
Vesselina Goranova-Marinova, Eirini Katodritou, Mamta Garg, Michael G. Kauffman, Paul G. Richardson, Lingling Li, Monica Galli, Sosana Delimpasi, Sebastian Grosicki, Jelena Bila, Galina Salogub, Dinesh Kumar Sinha, Holger W. Auner, Larry D. Anderson, Sybiryna Korenkova, Don A. Stevens, Melina Arazy, Reuben Benjamin, Supratik Basu, Jacqueline Jeha, Moshe Yair Levy, Artur Jurczyszyn, Nizar J. Bahlis, Jean Richard Saint-Martin, Jatin P. Shah, Hang Quach, Anna M. Liberati, Tuphan Kanti Dolai, Iryrna Kriachok, Roman Hájek, Anita A. Joshi, Darrell White, Michele Cavo, Sundar Jagannath, Meletios A. Dimopoulos, Xavier Leleu, Hanna Oliynyk, Pawel Robak, Maryana Simonova, Ganna Usenko, Ludek Pour, Maria V. Mateos, Ivan Spicka, Moshe E. Gatt, Atanas Radinoff, Craig T. Wallington-Beddoe, Jeevan Kumar, Vishnuvardhan Peddagali, Halyna Pylypenko, Thierry Facon, Christopher P. Venner, Donna E. Reece, Sharon Shacham, Maria Gavriatopoulou, Yi Chai, Mercedes Gironella, Vadim A Doronin, P. Moreau
Publikováno v:
Lancet (London, England). 396(10262)
Summary Background Selinexor combined with dexamethasone has shown activity in patients with heavily pre-treated multiple myeloma. In a phase 1b/2 study, the combination of oral selinexor with bortezomib (a proteasome inhibitor) and dexamethasone ind
Autor:
Emma C. Morris, Karl S. Peggs, Kirsty Thomson, Panagiotis D. Kottaridis, Noha Edwards, Stephanie Verfuerth, Andy C. Rawstron, Reuben Benjamin, Simon Richardson, Iftekhar Khan, Anthony H. Goldstone, Adele K. Fielding, Jagoda Sudak, Ronjon Chakraverty, Elisabeth Vandenberghe, Stephen Mackinnon
Publikováno v:
British Journal of Haematology. 160:640-648
Following reduced intensity-conditioned allogeneic stem cell transplantation (RIC allo-SCT) for chronic lymphocytic leukaemia (CLL), there is an inverse relationship between relapse and extensive chronic graft-versus-host disease (GVHD). We evaluated